Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS
· Delayed Price · Currency is USD
0.6800
-0.0100 (-1.45%)
Mar 31, 2025, 4:00 PM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of $53.33 million as of April 1, 2025. Its market cap has decreased by -34.07% in one year.
Market Cap
53.33M
Enterprise Value
32.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.68
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 48.70M to 53.33M, an increase of 9.50%. That is a compound annual growth rate of 1.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.82B |
| SS Innovations International | 1.76B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 720.71M |
| Elite Pharmaceuticals | 470.04M |
| Glass House Brands | 371.89M |
| Northwest Biotherapeutics | 318.00M |
| CytoDyn | 288.56M |